Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-16
1997-10-28
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 20, 514616, 514340, 514357, A61K 3700, C07K24100
Patent
active
056818203
ABSTRACT:
This invention herein relates to a method of treating a condition mediated by inhibition of .alpha..sub.v .beta..sub.3 integrins and a method of inhibiting tumor metastasis by administering a therapeutically effective amount of a compound having the following formula ##STR1## or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 4879313 (1989-11-01), Tjeong et al.
patent: 4952562 (1990-08-01), Klein et al.
Fok et al. "Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma inhibit platelet aggregation." Int. J. Peptide Res., 38, 124-130 (1991).
Greenspoon et al. "Structural Analysis of Integrin-Mediated Cell Functions by Novel Nonpeptide Surrogates of the Arg-Gly-Asp Sequence." Biochemistry, 32, 1001-1008 (1993).
McDowell et al. "From Peptide to Non-Peptide. The Elucidation of a Bioactive Conformation of the Arg-Gly-Asp Acid Recognition Sequence." J. Am. Chem. Soc., 116, 5069-5076 (1994).
G. D. Searle & Co.
Kovacevic Cynthia S.
Krass Frederick
Williams Roger A.
LandOfFree
Guanidinoalkyl glycine .beta.-amino acids useful for inhibiting does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidinoalkyl glycine .beta.-amino acids useful for inhibiting , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidinoalkyl glycine .beta.-amino acids useful for inhibiting will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026159